Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Kaufmann, Justus; Wollschlaeger, Daniel; Nikolaidou, Eirini et al.

Pain response to postoperative spinal radiotherapy. Manifestations of multiple myeloma as a predictor of overall survival

STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 199. 2023 S. S163-S164


Bostel, Tilman; Wollschlaeger, Daniel; Nikolaidou, Eirini et al.

Palliative Effects and Complications after Radiotherapy of spinal Bone Lesions in elderly Patients with Multiple Myeloma

STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 199. 2023 S. S163-S163


Schmalfeldt, Barbara; Schmidberger, Heinz

Paradigm shift in endometrial cancer

ONKOLOGIE. Bd. 29. H. 5. 2023 S. 386-387


Kreipe, Hans; Schmidt, M

Pathologie, Prognose und Prädiktion

Untch, Harbeck, Thomssen, Lüftner (Hrsg). Colloquium Senologie. München: Lukon 2023


Singer, Susanne; Bergelt, Corinna; Tribius, Silke et al.

Patient-reported outcomes in head and neck cancer treatment: relevance, challenges, and benefit

HNO. 2023


Bonifacius, Agnes; Lamottke, Britta; Tischer-Zimmermann, Sabine et al.

Patient-tailored adoptive immunotherapy with EBV-specific T cells from related and unrelated donors

JOURNAL OF CLINICAL INVESTIGATION. Bd. 133. H. 12. 2023


Schmidt, Marcus; Denkert, Carsten; Rhiem, Kerstin et al.

Personalized medicine-from translational research to clinical practice

GYNAKOLOGIE. Bd. 56. H. 5. 2023 S. 341-346


Depenbusch, Johanna; Sweegers, Maike G.; Aaronson, Neil K. et al.

PERSPECTIVEs on supervised exercise programs in people with metastatic breast cancer- a qualitative study in four European countries

SUPPORTIVE CARE IN CANCER. Bd. 31. H. 5. 2023


Brose, Alexander; Michalski, Kerstin; Ruf, Juri et al.

PET/CT reading for relapse in non-small cell lung cancer after chemoradiotherapy in the PET-Plan trial cohort

CANCER IMAGING. Bd. 23. H. 1. 2023


Nastoupil, Loretta J.; Hess, Georg; Pavlovsky, Miguel A. et al.

Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma

BLOOD ADVANCES. Bd. 7. H. 22. 2023 S. 7141-7150